Karolinska Development names new CEO
This article was originally published in Scrip
The Swedish investment company, Karolinska Development, has appointed Torbjorn Bjerke as its new CEO. He will replace Conny Bogentoft, who will become the company's chief scientific officer and with responsibility for the future development of the company's portfolio. Mr Bjerke will assume his new position once a successor for his current role – CEO of the Swedish firm Orexo – has been named. Karolinska Development, which began operations in 2003, now has a portfolio of 45 companies, which span across several therapeutic areas, and 21 potential first-in-class products.